Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials

James M Mountz; Thomas E Yankeelov; Daniel L Rubin; John M Buatti; Bradley J Erikson; Fiona M Fennessy; Robert J Gillies; Wie Huang; Michael A Jacobs; Paul E Kinahan; Charles M Laymon; Hannah M Linden; David A Mankoff; Lawrence H Schwartz; Hyunsuk Shim; Richard L Wahl

doi:10.1200/JCO.2014.55.8866

Back

Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials

Letter/Communication

Open access

Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials

James M Mountz, Thomas E Yankeelov, Daniel L Rubin, John M Buatti, Bradley J Erikson, Fiona M Fennessy, Robert J Gillies, Wie Huang, Michael A Jacobs, Paul E Kinahan, …

Journal of clinical oncology, Vol.32(19), pp.2115-2116

07/01/2014

DOI: 10.1200/JCO.2014.55.8866

PMCID: PMC4861229

PMID: 24868025

Files and links (1)

url

https://www.ncbi.nlm.nih.gov/pmc/articles/4861229View

Open Access

Abstract

United States

Inflammation - chemically induced

Predictive Value of Tests

Humans

National Cancer Institute (U.S.)

Treatment Outcome

Antineoplastic Agents - therapeutic use

Clinical Trials as Topic

Neoplasms - diagnosis

Inflammation - etiology

Disease Progression

Neoplasms - drug therapy

Research Support as Topic

Diagnostic Imaging - methods

Neoplasms - therapy

Neoplasms - radiotherapy

Antineoplastic Agents - pharmacology

Details

Title: Subtitle: Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials
Creators: James M Mountz - University of Pittsburgh, Pittsburgh, PA mountzjm@upmc.edu
Thomas E Yankeelov - Vanderbilt University, Nashville, TN
Daniel L Rubin - Stanford University, Palo Alto, CA
John M Buatti - University of Iowa, Iowa City, IA
Bradley J Erikson - Mayo Clinic, Rochester, MN
Fiona M Fennessy - Brigham and Women's Hospital, Boston, MA
Robert J Gillies - H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Wie Huang - Oregon Health and Science University, Portland, OR
Michael A Jacobs - Johns Hopkins University, Baltimore, MD
Paul E Kinahan - University of Washington, Seattle, WA
Charles M Laymon - University of Pittsburgh, Pittsburgh, PA
Hannah M Linden - University of Washington, Seattle, WA
David A Mankoff - University of Pennsylvania, Philadelphia, PA
Lawrence H Schwartz - Columbia University, New York, NY
Hyunsuk Shim - Emory University, Atlanta, GA
Richard L Wahl - Johns Hopkins University, Baltimore, MD
Resource Type: Letter/Communication
Publication Details: Journal of clinical oncology, Vol.32(19), pp.2115-2116
DOI: 10.1200/JCO.2014.55.8866
PMID: 24868025
PMCID: PMC4861229
NLM abbreviation: J Clin Oncol
ISSN: 0732-183X
eISSN: 1527-7755
Publisher: United States
Grant note: U01 CA140230 / NCI NIH HHS P01 CA042045 / NCI NIH HHS P30 CA047904 / NCI NIH HHS U01 CA140204 / NCI NIH HHS U01 CA172027 / NCI NIH HHS P30 CA086862 / NCI NIH HHS U01 CA148131 / NCI NIH HHS
Language: English
Date published: 07/01/2014
Academic Unit: Radiation Oncology; Neurosurgery; Otolaryngology
Record Identifier: 9984040387802771

Metrics

12 Record Views

15 Times Cited - Web of Science